Medicure Inc. (OTCMKTS:MCUJF) Short Interest Update

Medicure Inc. (OTCMKTS:MCUJF) was the target of a significant decrease in short interest in April. As of April 30th, there was short interest totaling 5,780 shares, a decrease of 50.5% from the April 15th total of 11,680 shares. Currently, 0.1% of the company’s stock are sold short. Based on an average daily volume of 182 shares, the short-interest ratio is currently 31.8 days.

Medicure Stock Performance

Shares of MCUJF stock remained flat at $0.80 during trading hours on Friday. The company has a 50-day simple moving average of $0.83 and a two-hundred day simple moving average of $0.84. The stock has a market cap of $8.39 million, a PE ratio of -1.64 and a beta of 0.97. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.77 and a current ratio of 1.02. Medicure has a twelve month low of $0.68 and a twelve month high of $0.97.

Medicure (OTCMKTS:MCUJF) last issued its quarterly earnings results on Thursday, April 23rd. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.04) by ($0.25). The business had revenue of $6.13 million for the quarter, compared to analyst estimates of $3.62 million. Medicure had a negative return on equity of 41.55% and a negative net margin of 24.61%.

About Medicure

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.